Arrowstreet Capital, Limited Partnership Enovis Corp Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$43.67 - $57.07 $6.42 Million - $8.39 Million	-147,040 Reduced 79.33%	38,316 $2.15 Million
Q3 2023 Nov 14, 2023	SELL	$51.65 - $65.54 $13.4 Million - $17 Million	-259,106 Reduced 58.3%	185,356 $9.77 Million
Q2 2023 Aug 14, 2023	SELL	$52.7 - $64.12 $1.69 Million - $2.05 Million	-31,977 Reduced 6.71%	444,462 $28.5 Million
Q1 2023 May 15, 2023	BUY	$49.5 - $65.92 $5.65 Million - $7.52 Million	114,049 Added 31.47%	476,439 $25.5 Million
Q4 2022 Feb 14, 2023	BUY	$44.83 - $57.43 $16.2 Million - $20.8 Million	362,390 New	362,390 $19.4 Million

311

60.2M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.44B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.